Overview of Dr. Kung
Dr. Andrew Kung is a pediatric hematologist/oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Stanford University School of Medicine and has been in practice 23 years. Dr. Kung accepts several types of health insurance, listed below. He is one of 95 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. He has more than 100 publications and over 500 citings.
Office
1275 York Avenue
New York, NY 10065
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1996 - 1999
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1994 - 1996
- Stanford University School of MedicineClass of 1994
Certifications & Licensure
- NY State Medical License 2013 - 2026
- MA State Medical License 1996 - 2013
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
- Elected Member Society for Pediatric Research
Publications & Presentations
PubMed
- 95 citationsEfficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.Claire M. Sauvageot, Jessica Weatherbee, Santosh Kesari, Susan Elizabeth Winters, Jessica W. Barnes
Neuro-Oncology. 2009-04-01 - 256 citationsHOXA9 is required for survival in human MLL-rearranged acute leukemiasJoerg Faber, Andrei V. Krivtsov, Matthew C. Stubbs, Renee Wright, Tina N. Davis
Blood. 2009-03-12 - 150 citationsMutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemiaBrenton G. Mar, Lars Bullinger, Kathleen M. McLean, Peter V. Grauman, Marian H. Harris
Nature Communications. 2014-03-24
Journal Articles
- Important Concerns over SARS-CoV-2 Infection in Children with Cancer—ReplyAndrew L Kung, Farid Boulad, JAMA Oncology
- COVID-19 in Children with Cancer in New York CityFarid Boulad, Mini Kamboj, Andrew L Kung, JAMA Oncology
- BRCA1-IRIS Promotes Human Tumor Progression Through PTEN Blockade and HIF-1α ActivationDavid M Livingston, Kimberly J Briggs, Andrew L Kung, Proceedings of the National Academy of Sciences
Authored Content
- COVID-19 in Children with Cancer in New York CityMay 2020
Press Mentions
- To Save Children with Cancer, Doctors Turn to New WeaponsAugust 5th, 2022
- Experiences from the Epicenter: Professional Impact of the COVID‐19 Pandemic on Genetic Counselors in New YorkNovember 23rd, 2020
- How Genomics Can Improve Cancer Care (At Techonomy Health)June 14th, 2017
- Join now to see all
Grant Support
- Targeting The ETS Transcription Factor Rearrangement EWS/FLI In Ewing'S SarcomaNational Institute On Drug Abuse2012
- Functionizing The Epigenome In Ewing SarcomaNational Cancer Institute2012
- Transcription Factor And Epigenetic Regulation Of Hypoxic Gene ExpressionNational Institute Of General Medical Sciences2008–2012
- A Novel Probe For Imaging ApoptosisNational Institute Of Biomedical Imaging And Bioengineering2010–2011
- Hypoxia Inducible Transcription In Antitumor StrategiesNational Cancer Institute2001–2005
Professional Memberships
- Member
- The American Society of Pediatric Hematology/OncologyMember
- Member
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Massachusetts Blue Care Elect PPO
First Health PPO
Great West PPO
Harvard Pilgrim HMOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Tufts Health Plan PPO
UniCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: